Notice to Long-Term Shareholders of Lifecore Biomedical, Inc. (NASDAQ: LFCR): Grabar Law Office Investigates Claims on Your Behalf as Securities Fraud Class Action Settles

Core Viewpoint - Grabar Law Office is investigating claims on behalf of shareholders of Lifecore Biomedical, Inc. regarding a securities fraud class action settlement, focusing on potential breaches of fiduciary duties by certain officers and directors [1][3]. Group 1: Settlement Details - A federal securities class action against Lifecore Biomedical and certain officers has reached a settlement of $3,750,000 [4]. - Shareholders who held shares before October 7, 2020, can seek corporate reforms, return of funds, and a court-approved incentive award at no cost [2][5]. Group 2: Allegations Against Lifecore - The class action complaint alleges that Lifecore made materially false and misleading statements about its business, operations, and prospects [3]. - Specific allegations include deficient internal controls over financial reporting, inaccurate financial statements requiring restatement, ineffective remediation efforts, and impaired ability to file periodic reports with the SEC [3].